ANNX+128.51%20.0%
BHVN-9.50%20.0%
DNLI+70.17%20.0%
KYMR+155.09%20.0%
VRTX+25.72%20.0%
As of Aug 6, 2026, 4:25 AM ET
Rare Diseases '25: CNS/Neuro Constituents
Annexon, Inc.ANNX | 20.0% | 0.75% | 2.87% | -9.90% | 5.40% | 6.97% | -4.11% | 173.98% | 128.51% | $879.8M |
Biohaven Ltd.BHVN | 20.0% | -0.87% | -4.82% | -15.08% | 0.96% | 20.73% | 18.32% | -42.44% | -9.50% | $2.05B |
Denali Therapeutics Inc.DNLI | 20.0% | 1.03% | 5.67% | -5.13% | 6.08% | 47.91% | 15.30% | 77.73% | 70.17% | $3.88B |
Kymera Therapeutics, Inc.KYMR | 20.0% | 1.04% | -4.60% | -8.09% | 2.01% | 35.56% | 15.47% | 300.15% | 155.09% | $8.68B |
Vertex Pharmaceuticals IncorporatedVRTX | 20.0% | 1.28% | 1.56% | -8.45% | 1.62% | 6.94% | -2.42% | 0.28% | 25.72% | $123.05B |
| Theme return | — | 0.65% | 0.14% | -6.07% | 3.66% | 30.97% | 13.16% | 96.65% | 84.44% | — |
| Average | 20.0% | 0.65% | 0.14% | -9.33% | 3.21% | 23.62% | 8.51% | 101.94% | 74.00% | $27.71B |
| Median | 20.0% | 1.03% | 1.56% | -8.45% | 2.01% | 20.73% | 15.30% | 77.73% | 70.17% | $3.88B |
| Std Dev | 0.0% | 0.78% | 4.17% | 3.27% | 2.10% | 16.10% | 9.69% | 123.49% | 61.42% | $47.75B |
| Min | 20.0% | -0.87% | -4.82% | -15.08% | 0.96% | 6.94% | -4.11% | -42.44% | -9.50% | $879.8M |
| Max | 20.0% | 1.28% | 5.67% | -5.13% | 6.08% | 47.91% | 18.32% | 300.15% | 155.09% | $123.05B |
| % Positive Tickers | 80.00% | 60.00% | 0.00% | 100.00% | 100.00% | 60.00% | 80.00% | 80.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Rare Diseases '25: CNS/Neuro tracks 5 publicly listed stocks in this theme: ANNX, BHVN, DNLI, KYMR, VRTX. See the constituent table for details.